# Pfizer (PFE) — News

PFE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/pfe/news

## Recent headlines

- [Fitch affirms Epif at 'BBB'; outlook stable](https://www.ainvest.com/news/fitch-affirms-epif-bbb-outlook-stable-2610) — AInvest Wire, Oct 14, 2026
  Fitch Ratings has affirmed its credit rating for Epif at 'BBB', with a stable outlook, reflecting the company's solid financial position and operational performance. The rating underscores Fitch's confidence in Epif's ability to maintain its creditworthiness amid evolving market conditions. The…
- [Pfizer showcases clinical advancements across infectious diseases at IDWeek 2026](https://www.ainvest.com/news/pfizer-showcases-clinical-advancements-infectious-diseases-idweek-2026-2610) — AInvest Wire, Oct 14, 2026
- [Enodia, Pfizer pact has potential value of more than $500M](https://www.ainvest.com/news/enodia-pfizer-pact-potential-500m-2610) — AInvest Wire, Oct 13, 2026
  Pharmaceutical company Pfizer Inc. (NYSE: PFE) has entered into a collaboration agreement with Enodia Therapeutics, a clinical-stage biotechnology firm, to develop and commercialize a novel therapeutic candidate. The partnership, which encompasses research, development, and potential…
- [Enodia Therapeutics: Pfizer will be responsible for all clinical, manufacturing, regulatory and commercial activities](https://www.ainvest.com/news/enodia-therapeutics-pfizer-responsible-clinical-manufacturing-regulatory-commercial-activities-2610) — AInvest Wire, Oct 13, 2026
- [Enodia Therapeutics announces research collaboration and license agreement with Pfizer to develop SEC61-targeting small molecules](https://www.ainvest.com/news/enodia-therapeutics-announces-research-collaboration-license-agreement-pfizer-develop-sec61-targeting-small-molecules-2610) — AInvest Wire, Oct 13, 2026

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [NVAX](https://www.lighthorse.io/tickers/nvax) — Novavax, Inc. - Common Stock
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).